NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will present at the Goldman Sachs Healthcare CEOs Unscripted conference on Thursday, January 5, 2012, in New York. Elliott Sigal, executive vice president, chief scientific officer & president, R&D, will participate in a Q&A session about the company at 4 p.m. EST.
Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
CONTACT:
Bristol-Myers Squibb
Media: Jennifer Fron Mauer, 609-252-6579
[email protected]
or
Investors: John Elicker, 609-252-4611
[email protected]
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical
MEDIA:
| Logo |